Grouped product items

SKU

Size

Availability

Price

Qty

G118955-0.5mg

0.5mg

Available within 4-8 weeks(?)

$1,244.90

G118955-1mg

1mg

Available within 4-8 weeks(?)

$2,240.90

G118955-2.5mg

2.5mg

Available within 4-8 weeks(?)

$5,040.90

G118955-10mg

10mg

Available within 4-8 weeks(?)

$18,144.90

Basic Description

Specifications & Purity	Moligand™, ≥95%(HPLC)
Biochemical and Physiological Mechanisms	Potent insulinotropic hormone synthesized by duodenal K-cells. High affinity GIP receptor agonist (EC50= 0.81 nM) that inhibits gastric acid secretion and stimulates pancreatic insulin release in response to glucose. Also affects lipid metabolism and disp
Storage Temp	Store at -20°C
Shipped In	Ice chest + Ice pads
Grade	Moligand™
Action Type	AGONIST
Mechanism of action	Agonist of GIP receptor
Product Description	Amino Acid Sequence Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Glnw Gastric Inhibitory Peptide (GIP), human is thought to act as an inhibitor of gastric functions.

Associated Targets(Human)

GIPR Tchem Gastric inhibitory polypeptide receptor (0 Activities)

Discover Target: GIPR

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Names and Identifiers

IUPAC Name	5-amino-2-[[2-[[2-[[4-amino-2-[[2-[[6-amino-2-[[2-[[2-[[4-amino-2-[[6-amino-2-[[6-amino-2-[[2-[[6-amino-2-[[5-amino-2-[2-[[2-[[2-[[2-[[4-amino-2-[[2-[[2-[[2-[[5-amino-2-[[5-amino-2-[[2-[[2-[[6-amino-2-[[2-[[2-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoylamino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]propanoylamino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]propanoylamino]-5-oxopentanoyl]amino]hexanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-5-oxopentanoic acid
INCHI	InChI=1S/C226H338N60O66S/c1-21-113(11)181(285-218(343)165(107-288)278-203(328)150(88-125-60-64-131(292)65-61-125)264-212(337)163(99-179(310)311)274-217(342)164(106-287)279-222(347)183(115(13)23-3)283-215(340)152(87-123-47-29-26-30-48-123)275-224(349)185(120(18)289)280-174(301)105-245-192(317)142(70-75-175(302)303)252-187(312)117(15)248-190(315)134(232)85-124-58-62-130(291)63-59-124)220(345)250-119(17)189(314)254-146(76-82-353-20)199(324)272-160(96-176(304)305)210(335)258-141(57-39-44-81-231)200(325)282-182(114(12)22-2)221(346)276-156(92-129-103-241-109-247-129)206(331)260-144(67-72-167(234)294)197(322)259-145(68-73-168(235)295)198(323)271-161(97-177(306)307)211(336)265-151(86-122-45-27-25-28-46-122)214(339)281-180(112(9)10)219(344)277-158(94-171(238)298)209(334)266-154(90-127-101-243-136-52-34-32-50-133(127)136)205(330)263-149(84-111(7)8)202(327)262-148(83-110(5)6)201(326)249-118(16)188(313)253-143(66-71-166(233)293)196(321)255-137(53-35-40-77-227)191(316)244-104-173(300)251-138(54-36-41-78-228)193(318)256-139(55-37-42-79-229)195(320)269-157(93-170(237)297)208(333)273-162(98-178(308)309)213(338)267-153(89-126-100-242-135-51-33-31-49-132(126)135)204(329)257-140(56-38-43-80-230)194(319)268-155(91-128-102-240-108-246-128)207(332)270-159(95-172(239)299)216(341)284-184(116(14)24-4)223(348)286-186(121(19)290)225(350)261-147(226(351)352)69-74-169(236)296/h25-34,45-52,58-65,100-103,108-121,134,137-165,180-186,242-243,287-292H,21-24,35-44,53-57,66-99,104-107,227-232H2,1-20H3,(H2,233,293)(H2,234,294)(H2,235,295)(H2,236,296)(H2,237,297)(H2,238,298)(H2,239,299)(H,240,246)(H,241,247)(H,244,316)(H,245,317)(H,248,315)(H,249,326)(H,250,345)(H,251,300)(H,252,312)(H,253,313)(H,254,314)(H,255,321)(H,256,318)(H,257,329)(H,258,335)(H,259,322)(H,260,331)(H,261,350)(H,262,327)(H,263,330)(H,264,337)(H,265,336)(H,266,334)(H,267,338)(H,268,319)(H,269,320)(H,270,332)(H,271,323)(H,272,324)(H,273,333)(H,274,342)(H,275,349)(H,276,346)(H,277,344)(H,278,328)(H,279,347)(H,280,301)(H,281,339)(H,282,325)(H,283,340)(H,284,341)(H,285,343)(H,286,348)(H,302,303)(H,304,305)(H,306,307)(H,308,309)(H,310,311)(H,351,352)
InChi Key	MGXWVYUBJRZYPE-UHFFFAOYSA-N
Canonical SMILES	CCC(C)C(C(=O)NC(CC1=CNC=N1)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CCCCN)C(=O)NC(CC7=CNC=N7)C(=O)NC(CC(=O)N)C(=O)NC(C(C)CC)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC1=CC=C(C=C1)O)N
PubChem CID	131954558
Molecular Weight	4983.53

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot Number	Certificate Type	Date	Item
C1922039	Certificate of Analysis	Jan 19, 2023	G118955

Chemical and Physical Properties

Solubility	Soluble to 1 (mg/mL) in water}

References

1. A J Moody,L Thim,I Valverde. (1984-07-09) The isolation and sequencing of human gastric inhibitory peptide (GIP).. FEBS letters, 172 ((2)): (142-148). [PMID:6745415]
2. Valeriya Lyssenko,Lena Eliasson,Olga Kotova,Kasper Pilgaard,Nils Wierup,Albert Salehi,Anna Wendt,Anna Jonsson,Yang Z De Marinis,Lisa M Berglund,Jalal Taneera,Alexander Balhuizen,Ola Hansson,Peter Osmark,Pontus Dunér,Charlotte Brøns,Alena Stancáková,Johanna Kuusisto,Marco Bugliani,Richa Saxena,Emma Ahlqvist,Timothy J Kieffer,Tiinamaija Tuomi,Bo Isomaa,Olle Melander,Emily Sonestedt,Marju Orho-Melander,Peter Nilsson,Sara Bonetti,Riccardo Bonadonna,Roberto Miccoli,Stefano Delprato,Piero Marchetti,Sten Madsbad,Pernille Poulsen,Allan Vaag,Markku Laakso,Maria F Gomez,Leif Groop. (2011-08-04) Pleiotropic effects of GIP on islet function involve osteopontin.. Diabetes, 60 ((9)): (2424-2433). [PMID:21810601]
3. Nigel Irwin,Jacqueline M E Francis,Peter R Flatt. (2011-08-20) Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats.. Biological chemistry, 392 ((10)): (909-918). [PMID:21851286]
4. Priya Sumithran,Luke A Prendergast,Elizabeth Delbridge,Katrina Purcell,Arthur Shulkes,Adamandia Kriketos,Joseph Proietto. (2011-10-28) Long-term persistence of hormonal adaptations to weight loss.. The New England journal of medicine, 365 ((17)): (1597-1604). [PMID:22029981]
5. Jennifer D Könitzer,Shreya Pramanick,Qi Pan,Robert Augustin,Sebastian Bandholtz,William Harriman,Shelley Izquierdo. (2017-01-06) Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor.. mAbs, 9 ((3)): (536-549). [PMID:28055305]
6. H Yajima,N Fujii,K Akaji,M Sakurai,M Nomizu,K Mizuta,M Aono,M Moriga,K Inoue,R Hosotani. (1985-08-01) Synthesis of a 42 residue peptide corresponding to the entire amino acid sequence of human GIP.. Chemical & pharmaceutical bulletin, 33 ((8)): (3578-3581). [PMID:3910280]
7. Sabrina Paratore,Maria Teresa Ciotti,Magali Basille,David Vaudry,Antonietta Gentile,Rosalba Parenti,Pietro Calissano,Sebastiano Cavallaro. (2011-09-17) Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival.. Central nervous system agents in medicinal chemistry, 11 ((3)): (210-222). [PMID:21919873]

Solution Calculators

Molarity Calculator

Determine the necessary mass, volume, or concentration for preparing a solution.

Dilution Calculator

Determine the dilution needed to prepare a stock solution.

Gastric Inhibitory Polypeptide human - ≥95% (HPLC), high purity , CAS No.100040-31-1, Agonist of GIP receptor

Basic Description

Associated Targets(Human)

Names and Identifiers

Certificates

Certificate of Analysis(COA)

Chemical and Physical Properties

Related Documents

References

Solution Calculators

Molarity Calculator

Dilution Calculator

Reconstitution Calculator

SKU	Size	Availability	Price
G118955-0.5mg	0.5mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$1,244.90
G118955-1mg	1mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$2,240.90
G118955-2.5mg	2.5mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$5,040.90
G118955-10mg	10mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$18,144.90